SERUM INTERFERONA (IFNA) LEVELS AND SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) DISEASE ACTIVITY IN SLE PATIENTS IN ESTONIA. A PROSPECTIVE COHORT STUDY OF 40 SLE PATIENTS IN ESTONIA

被引：1
作者：
Meisalu, S. [1 ]
Kisand, K. [2 ]
Haljasmagi, L. [2 ]
机构：
[1] East Tallinn Cent Hosp, Rheumatol, Tallinn, Estonia
[2] Univ Tartu, Biomed, Tartu, Estonia
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2023年 / 82卷
关键词：
Systemic lupus erythematosus; Real-world evidence; Descriptive studies;
D O I：
10.1136/annrheumdis-2023-eular.5020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0692
引用
收藏
页码：1549 / 1550
页数：2
相关论文
共 50 条
  • [21] Application of SLE-DAS to assess subcutaneous belimumab efficacy in a cohort of systemic lupus erythematosus patients
    Ceccarelli, F.
    Picciariello, L.
    Natalucci, F.
    Moretti, V.
    Spinelli, F. R.
    Alessandri, C.
    Conti, F.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (07) : 1491 - 1494
  • [22] A comparison of five health status instruments in patients with systemic lupus erythematosus (SLE)
    Gladman, DD
    Urowitz, MB
    Ong, A
    Gough, J
    MacKinnon, A
    LUPUS, 1996, 5 (03) : 190 - 195
  • [23] A prospective study of obesity and risk of systemic lupus erythematosus (SLE) among Black women
    Cozier, Yvette C.
    Barbhaiya, Medha
    Castro-Webb, Nelsy
    Conte, Carolyn
    Tedeschi, Sara
    Leatherwood, Cianna
    Costenbader, Karen H.
    Rosenberg, Lynn
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2019, 48 (06) : 1030 - 1034
  • [24] Clinical correlations of serum anti-dsDNA immunoglobulin subfamilies in patients with systemic lupus erythematosus (SLE)
    Wang, Jing Jing
    Lin, Ming Wei
    Suan, Dan
    Beroukas, Dimitra
    Gordon, Tom P.
    Lee, Adrian Y. S.
    AUTOIMMUNITY, 2025, 58 (01)
  • [25] Elevated serum levels of soluble membrane cofactor protein (CD46, MCP) in patients with systemic lupus erythematosus (SLE)
    Kawano, M
    Seya, T
    Koni, I
    Mabuchi, H
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 116 (03) : 542 - 546
  • [26] Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
    Isenberg, David
    Li, Yong
    Wax, Stephen
    Wofsy, David
    Gordon, Caroline
    ARTHRITIS RESEARCH & THERAPY, 2014, 16
  • [27] Impact of disease activity patterns on health-related quality of life (HRQoL) in patients with systemic lupus erythematosus (SLE)
    Elefante, Elena
    Gualtieri, Luca
    Schiliro, Davide
    Stagnaro, Chiara
    Signorini, Viola
    Zucchi, Dina
    Cardelli, Chiara
    Carli, Linda
    Ferro, Francesco
    Tani, Chiara
    Mosca, Marta
    LUPUS SCIENCE & MEDICINE, 2024, 11 (02):
  • [28] Therapeutic changes of systemic lupus erythematosus (SLE) patients in pregnancy and feto-maternal outcomes: a retrospective cohort study
    Al-Husban, Naser
    Abu-Hassan, Diala Walid
    Saleem, Ro'ya Ali Abu
    Al-Abdallat, Lara
    Alhusban, Alhareth Eid
    Adwan, Marwan H.
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2024, 52 (01)
  • [29] Levels of lupus autoantibodies in pregnant SLE patients: Correlations with disease activity and pregnancy outcome
    Tomer, Y
    Viegas, OAC
    Swissa, M
    Koh, SCL
    Shoenfeld, Y
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1996, 14 (03) : 275 - 280
  • [30] Effects of atacicept on disease activity in patients with moderate to severe systemic lupus erythematosus: APRIL-SLE randomized trial
    David Isenberg
    Yong Li
    Stephen Wax
    David Wofsy
    Caroline Gordon
    Arthritis Research & Therapy, 16
12345